Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease

Hou, Jyhgong Gabriel; Wu, Lung‐Sheng; Moore, Suzanne P.; Ward, Constance; York, Michele K.; Atassi, Farah; Fincher, Linda; Nelson, Naomi; Sarwar, Aliya; Lai, Eugene C.

doi:10.1016/j.parkreldis.2011.12.007

Cited by 52 publications

(51 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nonadherence to regular antiparkinsonian medication dosing schedules during hospitalization was reported in previous studies Hou et al, 2012;Wood, Neumiller, Carlson, Setter, & Corbett, 2010). For instance, 46.3% of patients did not receive antiparkinsonian medications on time, and 30% of patients had three or more doses that were missed because of lack of availability of the medication on the floor (Wood et al, 2010).…”

Section: Medication Administration In Hospitals and Long-term Care Fasupporting

confidence: 52%

“…During the period of hospitalization for a patient with PD, antiparkinsonian medication administration is mostly based on hospital schedules (Aminoff et al, 2011;Hou et al, 2012). Nonadherence to regular antiparkinsonian medication dosing schedules during hospitalization was reported in previous studies Hou et al, 2012;Wood, Neumiller, Carlson, Setter, & Corbett, 2010).…”

Section: Medication Administration In Hospitals and Long-term Care Famentioning

confidence: 90%

“…For instance, 46.3% of patients did not receive antiparkinsonian medications on time, and 30% of patients had three or more doses that were missed because of lack of availability of the medication on the floor (Wood et al, 2010). Correct administration of medication was also lower during the first 2 days postadministration compared with subsequent days and was higher for patients who had neurological consultants (Hou et al, 2012).…”

Section: Medication Administration In Hospitals and Long-term Care Famentioning

confidence: 92%

See 2 more Smart Citations

Medication Adherence in People With Parkinson Disease

Shin

Habermann

2016

Journal of Neuroscience Nursing

View full text Add to dashboard Cite

Parkinson disease (PD) is the second most common neurodegenerative disorder in the United States. Because there is no cure for PD currently, pharmacological therapy is the mainstay of PD symptom management. Despite the importance of medication adherence in PD, several studies have reported medication nonadherence and/or suboptimal adherence. This literature review provides an overview of medication adherence issues in people with PD. Articles were identified for this study using computerized database searches and journal hand searches. Of the 72 medication adherence articles reviewed, the following articles were eligible for this review: (a) 10 articles measuring medication adherence in people with PD, (b) four medication adherence intervention articles, and (c) six studies of medication adherence in hospitalized settings. The importance of adherence assessment and strategies in improving medication adherence are discussed with the goal of improving symptom management and clinical outcomes in people with PD. Because medication taking is a complex and multifaceted phenomena, patient-centered, theory-driven interventions are needed to improve medication adherence and quality of care and life in people with PD.

show abstract

Section: Medication Administration In Hospitals and Long-term Care Fasupporting

confidence: 52%

Section: Medication Administration In Hospitals and Long-term Care Famentioning

confidence: 90%

Section: Medication Administration In Hospitals and Long-term Care Famentioning

confidence: 92%

See 1 more Smart Citation

Medication Adherence in People With Parkinson Disease

Shin

Habermann

2016

Journal of Neuroscience Nursing

View full text Add to dashboard Cite

show abstract

“…We are aware of only one other published study that reports timeliness of PD medication administration accurately using data from an electronic drug prescription and administration system; this US study reported 8% of medication was omitted and 8% was given late [23]. In a UK-based study of 51 PD patients admitted to surgical departments, 12% of PD medication was omitted [8].…”

Section: Discussionmentioning

confidence: 99%

Does a specialist unit improve outcomes for hospitalized patients with Parkinson's disease?

Skelly

Brown

Fakis

et al. 2014

Parkinsonism & Related Disorders

View full text Add to dashboard Cite

ObjectiveSuboptimal management of Parkinson's disease (PD) medication in hospital may lead to avoidable complications. We introduced an in-patient PD unit for those admitted urgently with general medical problems. We explored the effect of the unit on medication management, length of stay and patient experience.MethodsWe conducted a single-center prospective feasibility study. The unit's core features were defined following consultation with patients and professionals: specially trained staff, ready availability of PD drugs, guidelines, and care led by a geriatrician with specialty PD training. Mandatory staff training comprised four 1 h sessions: PD symptoms; medications; therapy; communication and swallowing. Most medication was prescribed using an electronic Prescribing and Administration system (iSOFT) which provided accurate data on time of administration. We compared patient outcomes before and after introduction of the unit.ResultsThe general ward care (n = 20) and the Specialist Parkinson's Unit care (n = 24) groups had similar baseline characteristics. On the specialist unit: less Parkinson's medication was omitted (13% vs 20%, p < 0.001); of the medication that was given, more was given on time (64% vs 50%, p < 0.001); median length of stay was shorter (9 days vs 13 days, p = 0.043) and patients' experience of care was better (p = 0.01).DiscussionIf replicated and generalizable to other hospitals, reductions in length of stay would lead to significant cost savings. The apparent improved outcomes with Parkinson's unit care merit further investigation. We hope to test the hypothesis that specialized units are cost-effective and improve patient care using a randomized controlled trial design.

show abstract

“…Report adverse reactions . All adverse drug effects or reactions that happen to patients with Parkinson's disease should be reported to the primary neurologist who is taking care of this patient, because a dose adjustment, change to a different medication or gradual discontinuation of a medication may be necessary …”

Section: Delayed Administration and Contraindicated Drugs Place Hospimentioning

confidence: 99%

Medication Safety

2015

J Pharm Pract Res

View full text Add to dashboard Cite

Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease

Cited by 52 publications

References 22 publications

Medication Adherence in People With Parkinson Disease

Medication Adherence in People With Parkinson Disease

Does a specialist unit improve outcomes for hospitalized patients with Parkinson's disease?

Medication Safety

Contact Info

Product

Resources

About